Literature DB >> 8504975

Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.

K Nakano1, K Chijiiwa.   

Abstract

The reduced metastability of biliary cholesterol in the gall bladder bile of patients with cholesterol gall stones has been well shown. The purpose of this study was to examine the hypothesis that such a difference in metastability already exists in hepatic bile. Paired hepatic and gall bladder bile samples were collected from 10 patients with cholesterol gall stones and six patients without gall stones. Cholesterol nucleation time, biliary lipid concentration, vesicular cholesterol distribution, and biliary protein concentration were measured and compared. The nucleation time in the hepatic bile of patients with cholesterol gall stones was significantly shorter than the gall stone free patients (8.2 (7.2) v 15.7 (5.8) days, p < 0.05), and was associated with a greater concentration of biliary lipid despite the lack of a difference in the cholesterol saturation index (CSI) and total protein concentration. During the storage of bile in the gall bladder, the nucleation time became quicker in the patients with cholesterol gall stone (2.9 (1.7) days) while it was similar in the gall stone free patients (17.3 (5.7) days) compared with that of the corresponding hepatic bile. These differences were associated with a higher CSI (1.44 (0.33) v 1.13 (0.14), p < 0.05) and a greater vesicular cholesterol distribution (19.7 (11.9) v 4.4 (1.4)%, p < 0.01) in the patients with cholesterol gall stones than the gall stone free patients. The concentrations of total lipid and protein in gall bladder bile were not significantly different between the two groups. In conclusion, patients with cholesterol gall stones produce less metastable hepatic bile by the evidence of shorter nucleation time. During the storage of the bile in the gall bladder, the metastability is reduced further only in the cholesterol gall stone patients but not in the gall stone free patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504975      PMCID: PMC1374194          DOI: 10.1136/gut.34.5.702

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  37 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones.

Authors:  S P Lee; J T LaMont; M C Carey
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

3.  The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.

Authors:  M C Carey; D M Small
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

4.  Proteins of guinea-pig bile: selective resorption in the gall bladder.

Authors:  W G John; B M Mullock; R H Hinton
Journal:  Biosci Rep       Date:  1983-04       Impact factor: 3.840

5.  Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile.

Authors:  R T Holzbach; A Kibe; E Thiel; J H Howell; M Marsh; R E Hermann
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

6.  Supersaturated bile from obese patients without gallstones supports cholesterol crystal growth but not nucleation.

Authors:  M J Whiting
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

7.  Critical tables for calculating the cholesterol saturation of native bile.

Authors:  M C Carey
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

8.  Evidence for a potent nucleating factor in the gallbladder bile of patients with cholesterol gallstones.

Authors:  M J Burnstein; R G Ilson; C N Petrunka; R D Taylor; S M Strasberg
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

9.  Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.

Authors:  S H Gollish; M J Burnstein; R G Ilson; C N Petrunka; S M Strasberg
Journal:  Gut       Date:  1983-09       Impact factor: 23.059

10.  Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.

Authors:  K R Holan; R T Holzbach; R E Hermann; A M Cooperman; W J Claffey
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  3 in total

1.  The effects of dietary phospholipids enriched with phosphatidylethanolamine on bile and red cell membrane lipids in humans.

Authors:  R Pakula; F M Konikoff; M Rubin; Y Ringel; Y Peled; A Tietz; T Gilat
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

2.  Human gallbladder mucosal function: effects on intraluminal fluid and lipid composition in health and disease.

Authors:  S Ginanni Corradini; G Yamashita; H Nuutinen; A Chernosky; C Williams; L Hays; M L Shiffman; R M Walsh; J Svanvik; P Della Guardia; L Capocaccia; R T Holzbach
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

3.  Serum and bile lipid levels in patients with and without gallstones.

Authors:  W H Tang
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.